Biochemical evaluation of low dose of urokinase in acute myocardial infarction. A double-blind study.
作者信息
Gormsen J, Tidstrom B, Feddersen C, Ploug J
出版信息
Acta Med Scand. 1973;194(3):191-8. doi: 10.1111/j.0954-6820.1973.tb19429.x.
Abstract
摘要
相似文献
1
Biochemical evaluation of low dose of urokinase in acute myocardial infarction. A double-blind study.
Acta Med Scand. 1973;194(3):191-8. doi: 10.1111/j.0954-6820.1973.tb19429.x.
2
Experimental and clinical studies on the thrombin-like enzyme from the venom of Bothrops atrox. On the primary structure of fragment E.关于矛头蝮蛇毒类凝血酶的实验与临床研究。片段E的一级结构。
Acta Physiol Scand Suppl. 1973;400:1-47.
3
Free fatty acids (FFA)--blood clotting, fibrinolysis and platelet function.
Scand J Haematol. 1974;13(1):64-71. doi: 10.1111/j.1600-0609.1974.tb00236.x.
4
5
Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre study.急性心肌梗死患者静脉注射茴香酰化纤溶酶原链激酶激活剂复合物或肝素后凝血与纤溶分析。一项比利时多中心研究。
Drugs. 1987;33 Suppl 3:253-60. doi: 10.2165/00003495-198700333-00047.
6
[Urokinase "Green Cross", a new urokinase preparation. II. In vivo studies].[“绿十字”尿激酶，一种新型尿激酶制剂。II. 体内研究]
Int Z Klin Pharmakol Ther Toxikol. 1969 Apr;2(2):142-9.
7
Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.对急性心肌梗死患者使用茴香酰化纤溶酶原链激酶激活剂复合物和链激酶的血液学影响。IRS II研究中期报告。
Drugs. 1987;33 Suppl 3:247-52. doi: 10.2165/00003495-198700333-00046.
8
The use of tenecteplase in acute myocardial infarction.
Kardiologiia. 2007;47(1):37-46.
9
[Systemic effects of thrombolytic therapy].[溶栓治疗的全身效应]
Haematologica. 1991 Jun;76 Suppl 3:281-90.
引用本文的文献
1
A Double-Blind Multicenter Comparison of the Efficacy and Safety of Saruplase and Urokinase in the Treatment of Acute Myocardial Infarction: Report of the SUTAMI Study Group.沙芦普酶与尿激酶治疗急性心肌梗死疗效及安全性的双盲多中心比较：SUTAMI研究组报告
J Thromb Thrombolysis. 1995;2(2):117-124. doi: 10.1007/BF01064379.
2
Is there a need to control the placebo in placebo controlled trials?在安慰剂对照试验中是否有必要对安慰剂进行控制？
Heart. 1997 Feb;77(2):95-6. doi: 10.1136/hrt.77.2.95.
3
Thrombolytic therapy in acute myocardial infarction. A perspective.急性心肌梗死的溶栓治疗。一种观点。
Drugs. 1987;33 Suppl 3:1-12. doi: 10.2165/00003495-198700333-00002.
Zotero 插件